systhane has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
*Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, L; Bhattacharya, A; Brinker, A; Buckley, B; Guo, G; Henry, Z; Kong, B; Taylor, R | 1 |
| de Novellis, F; Lamberti, M; Pirozzi, AVA; Schiraldi, C; Stellavato, A | 1 |
2 other study(ies) available for systhane and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Myclobutanil-mediated alteration of liver-gut FXR signaling in mice.
Topics: Animals; Bile Acids and Salts; Humans; Intestines; Liver; Male; Mice; Mice, Inbred C57BL; Nitriles; Non-alcoholic Fatty Liver Disease; RNA-Binding Proteins; Triazoles | 2023 |
Myclobutanil worsens nonalcoholic fatty liver disease: An in vitro study of toxicity and apoptosis on HepG2 cells.
Topics: Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-X Protein; Cell Death; Cytochromes c; Fatty Acids; Fungicides, Industrial; Hep G2 Cells; Hepatocytes; Humans; L-Lactate Dehydrogenase; Lipid Metabolism; Myeloid Cell Leukemia Sequence 1 Protein; Nitriles; Non-alcoholic Fatty Liver Disease; Triazoles | 2016 |